Friday, May 13, 2016
Biostage Says biostage currently expects to complete its ind filing by year-end 2016.
Successfully Regenerates Esophagus In Groundbreaking Pre-Clinical work with mayo clinic; data provides 'proof of concept' to seek fda approval for clinical trials.
Source : reuters.com
